# KCAS Bio: Science Accelerated

> KCAS Bio is a leading Bioanalytical CRO provider with a proven record of drug development worldwide across complex therapeutic modalities\.

Generated by Yoast SEO v28.6, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Services](https://kcasbio.com/solutions/services/): Bioanalytical and biomarker services based on a deep understanding of your drug development and business ambitions\. KCAS Bio understands the importance of speed and flexibility, providing comprehensive GLP \(good laboratory practice\)/GCP \(good clinical practice\), and non\-GLP services as an extension of your laboratory team\.
- [Solutions](https://kcasbio.com/solutions/)
- [Quality Commitment](https://kcasbio.com/about-us/quality-commitment/): Although the Quality Department is independent of Laboratory Operations, both areas work within a culture of quality to achieve regulatory compliance, meet quality requirements and satisfy client expectations\. Quality is built into our DNA and is every employee’s responsibility\.
- [Accelerating Bioanalytical and Biomarker Development](https://kcasbio.com/): We are KCAS Bio\. The full\-service bioanalytical and biomarker solutions partner, helping to accelerate the discovery and development of life\-changing drugs\. Smoothly, safely and sustainably\.
- [Technology](https://kcasbio.com/solutions/technology/): Cutting\-edge platforms and instrumentation that accelerate the discovery and development of life\-changing drugs\. KCAS Bio has the capacity to scale and adapt quickly, and our forward\-thinking approach means providers often give us access to new technologies first

## Posts
- [PBSS: From Preclinical to Clinical: Across Therapeutic Modalities](https://kcasbio.com/events/join-kcas-bio-at-pbss-seattle/)
- [Cross\-Species Flow Cytometry in NHP, Minipig, and Dog: Will Your Immune Biomarker Data Translate to the Clinic?](https://kcasbio.com/blogs/immunophenotyping-across-species-looking-beyond-mice-and-humans/)
- [Immunogenicity and Bioassay Summit](https://kcasbio.com/events/immunogenicity-and-bioassay-summit/)
- [AAPS PharmSci 360](https://kcasbio.com/events/aaps-pharmsci-360/)
- [How Standardized Cell Labeling Could Fix Flow Cytometry’s Data Problem](https://kcasbio.com/webinars/flow-cytometry-standardization-ai-cell-labeling/)

## Services
- [Flow Cytometry Services](https://kcasbio.com/services/flow-cytometry-services/): As a leader in non\-GLP and GLP/GCP outsourcing of flow cytometry on a global scale, KCAS Bio offers spectral flow cytometry and conventional flow cytometry, as well as cell sorting services, validated panels, and proteomic analysis service to support non\-clinical and clinical studies\.
- [Pharmacokinetics](https://kcasbio.com/services/pk-services/): KCAS Bio provides bioanalytical services supporting pharmacokinetic \(PK\) studies across preclinical and clinical development\. Services focus on the quantitative bioanalysis using validated and fit\-for\-purpose analytical methods\.
- [Large Molecule Bioanalysis by LBA](https://kcasbio.com/services/large-molecule-bioanalysis-by-lba/): KCAS Bio is an industry leading expert in Large Molecule Bioanalysis to quantify proteins, antibodies and several other large molecule modalities in various fluids and tissues from early discovery through clinical phases\.
- [Large Molecule Bioanalysis by Hybrid LC\-MS/MS](https://kcasbio.com/services/hybrid-lcms-assays/): As a leader in non\-GLP and GLP/GCP outsourcing of hybrid LC\-MS/MS, KCAS Bio’s Hybrid LC\-MS/MS platform provides high\-sensitivity bioanalytical services for complex and emerging therapeutic modalities, delivering precise, reliable data to support development programs\.
- [Dose Formulation Services](https://kcasbio.com/services/dose-formulation-analysis/): The KCAS Bio team is experienced with small molecules, peptides, proteins, siRNA, antibodies, and antibody\-drug conjugates in all types of vehicles supporting in\-vivo toxicology, eco\-toxicology, geno\-toxicology and other formulation studies\. We are skilled in formulation stability and compatibility studies\. In addition, KCAS Bio offers Certificate of Analysis \(CoA\) and Certificate of Testing \(CoT\) services\.

## Therapeutic Areas
- [Gastrointestinal](https://kcasbio.com/therapeutic-areas/gastrointestinal/): Gastrointestinal disorders include various conditions such as IBD \(like Crohn's disease and ulcerative colitis\), IBS, GERD and Celiac Disease\. KCAS Bio has extensive experience in conducting gastrointestinal studies\. Our team is made up of dedicated drug development experts with significant experience in conducting studies for experimental therapeutics for diseases and conditions that include everything from acid reflux and indigestion to IBS and Celiac\.
- [Respiratory](https://kcasbio.com/therapeutic-areas/respiratory/): KCAS can monitor the status of the immune system both during and after respiratory infection to understand the infection/recovery pathway, evaluate relapse factors versus true recovery, and the mechanism of cytokine response\. Ready to perform molecular testing, flow cytometric immunophenotyping, cytokine profiling in vitro and in vivo, as well as retrospective studies, KCAS has experience with whole blood, fresh, frozen or fixed PBMCs, lymphoid tissue, respiratory samples, serum, and plasma\.
- [Oncology](https://kcasbio.com/therapeutic-areas/oncology/): KCAS Bio has the expertise to support the Immuno\-oncology field\. We have expertise in flow cytometry, ELISPOTs, cell based assays and multiple biomarkers for the development of new drugs\. Whether it is in\-vitro discovery method or support of a phase III trial, we can assist you\. We provide reliable and defendable data while continuing to help our partners develop drugs for the advancement of world health\.
- [Renal](https://kcasbio.com/therapeutic-areas/renal/): The team at KCAS has expertise in developing renal/kidney testing that results in quality data for our customers\. In fact, KCAS has been called upon in the past to develop challenging assays for our clients who have had issues with the solubility of their compounds in the kidney\. Our knowledge and experience allows these customers to continue developing their drugs with a full understanding of the role renal function plays in that development\.
- [Rare Diseases](https://kcasbio.com/therapeutic-areas/rare-diseases/): There are a number of considerations when developing an assay to monitor a class of biomarkers for orphan or rare diseases\. KCAS has validated an assay for 20 amino acids \(20\-plex\) that has been applied to support studies in metabolism and rare disease\. KCAS is interested in increasing our suite of biomarker assays\. We are happy to develop and qualify custom methods or collaborate on more general assays for rare/orphan diseases\.

## Technology
- [Hybrid LC\-MS/MS](https://kcasbio.com/technology/hybrid-lcms-ms/): KCAS Bio has a team of experts specializing in hybrid Liquid Chromatography Mass Spectrometry \(LC\-MS/MS\)\. With deep knowledge and broad and experience, they quickly adapt experiment approaches when issues arise\.
- [Ligand Binding Assays](https://kcasbio.com/technology/ligand-binding-assays/): With extensive experience in ligand binding assays \(LBA\), advanced technological capabilities, and highly trained personnel, KCAS Bio closely collaborates with clients to offer a wide range of approaches to develop LBA methods spanning from the initial discovery phase to clinical studies\.
- [Meso Scale Discovery](https://kcasbio.com/technology/meso-scale-discovery/): At KCAS Bio, our highly trained scientific team utilizes Meso Scale Discovery \(MSD\) to analyze single or multiplexed analytes to femtogram detection levels to support non\-clinical and clinical PK, PD/Biomarker, and immunogenicity testing\.
- [ELISpot Testing](https://kcasbio.com/technology/elispot/): Whether you want to measure the efficacy of your vaccine or the safety of your drug or cell and gene therapy, KCAS Bio has expertise in offering ELISpot support to assess immune cell functionalities\.
- [Luminex](https://kcasbio.com/technology/luminex/): KCAS Bio, relying on this Luminex technology, provides you with a quick simultaneous measurement of up to 50 analytes, in a small sample volume, while overcoming multiplex\-related challenges encountered along the way\. 

## Categories
- [Blogs](https://kcasbio.com/blogs/)
- [Events](https://kcasbio.com/events/)
- [Podcasts](https://kcasbio.com/podcasts/)
- [Videos](https://kcasbio.com/videos/)
- [Podcasts \- The Weekly Bioanalysis](https://kcasbio.com/podcasts/the-weekly-bioanalysis/)

## Tags
- [Flow Cytometry](https://kcasbio.com/tag/flow-cytometry/)
- [Biomarkers](https://kcasbio.com/tag/biomarkers/)
- [Hybrid LC\-MS/MS](https://kcasbio.com/tag/hybrid-lc-ms-ms/)
- [Ligand Binding Assays \(LBA\)](https://kcasbio.com/tag/ligand-binding-assays-lba/)
- [About KCAS Bio](https://kcasbio.com/tag/about-kcasbio/)

## Optional
- [Sitemap index](https://kcasbio.com/sitemap_index.xml)